ITEM METADATA RECORD
Title: Innovative thrombolytic strategy using a heterodimer diabody against TAFI and PAI-1 in mouse models of thrombosis and stroke
Authors: Wyseure, Tine
Rubio, Marina
Denorme, Frederik
Martinez de Lizarrondo, Sara
Peeters, Miet
Gils, Ann
De Meyer, Simon
Vivien, Denis
Declerck, Paul # ×
Issue Date: Feb-2015
Publisher: W.B. Saunders
Series Title: Blood vol:125 issue:8 pages:1325-32
Abstract: Circulating thrombin-activatable fibrinolysis inhibitor (TAFI) and plasminogen activator inhibitor-1 (PAI-1) are causal factors for thrombolytic failure. Therefore, we evaluated an antibody-engineered bispecific inhibitor against TAFI and PAI-1 (heterodimer diabody, Db-TCK26D6x33H1F7) in several mouse models of thrombosis and stroke. Prophylactic administration of the diabody (0.8mg/kg) in a thromboplastin-induced model of thromboembolism led to decreased lung fibrin deposition. In a model of cerebral ischemia/reperfusion, diabody administration (0.8mg/kg, 1h post occlusion) led to a mitigated cerebral injury with a 2.3-fold reduced lesion and improved functional outcomes. In a mouse model of thrombin-induced middle cerebral artery occlusion (MCAo), the efficacy of the diabody was compared to the standard thrombolytic treatment with recombinant tissue-type plasminogen activator (tPA). Early administration of diabody (0.8mg/kg, 20min post occlusion) caused a 2-fold decrease in brain lesion size, whereas that of tPA (10mg/kg) had a much smaller effect. Delayed administration of diabody or tPA (90min post occlusion) had no effect on lesion size, whereas the combined administration of diabody with tPA caused a 1.7-fold decrease in lesion size. In contrast to tPA, the diabody did not increase accumulative bleeding. In conclusion, administration of a bispecific inhibitor against TAFI and PAI-1 results in a prominent profibrinolytic effect in mice without increased bleeding.
ISSN: 0006-4971
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Therapeutic and Diagnostic Antibodies (+)
Cardiovascular Sciences, Campus Kulak Kortrijk
Department of Cardiovascular Sciences - miscellaneous
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Generated first edition pdf_addl_pappdf13515023.pdf Accepted 1451KbAdobe PDFView/Open

 


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science